Modus Create Achieves AWS Life Sciences Competency Status, Strengthening Its Commitment to Digital and AI Transformation in Pharma
The AWS Life Sciences Competency differentiates Modus Create as an AWS Partner with validated technical proficiency, regulatory alignment, and a strong record of customer success.
The AWS Life Sciences Competency differentiates Modus Create as an AWS Partner with validated technical proficiency, regulatory alignment, and a strong record of customer success. To earn the designation, AWS Partners must demonstrate deep domain expertise and the ability to deliver measurable outcomes across drug discovery, clinical development, and commercialization.
A recent project that Modus Create developed which reinforces its expertise in digital and AI transformation was the launch of EVERSANA ORCHESTRATE™ MLR, built for EVERSANA, a leading provider of commercial services to the life sciences industry. The solution reduces the medical, legal, and regulatory review process timelines by nearly 50%.
'The AI expertise of the Modus Create team, together with AWS, enabled us to build a compliant, scalable solution to meet the growing needs of our customers,' said Faruk Capan, Chief Innovation Officer, EVERSANA.
AWS is enabling scalable, flexible, and cost-effective solutions from startups to global enterprises. To support the seamless integration and deployment of these solutions, AWS established the AWS Competency Program to help customers identify AWS Partners with deep industry experience and expertise.
Modus Create helps life sciences organizations modernize legacy platforms, implement compliant generative AI, and streamline global operations through secure, data-driven architectures. Its cloud solutions are designed for scalability, interoperability, and regulatory compliance — enabling customers to accelerate time-to-insight and unlock high-value AI use cases across the enterprise.
'Earning the AWS Life Sciences Competency designation is a huge accomplishment and a testament to the dedication and expertise of Modus Create's product engineering teams and how they are helping pharmaceutical and life sciences companies revolutionize the industry,' said Sarah McCasland, Chief Strategy Officer at Modus Create. 'By helping these enterprises become digital-first organizations through harnessing AI and cloud technologies with AWS, our life sciences clients can accelerate their Pharma 4.0 initiatives to drive innovation and business growth.'
With experience serving both early-stage biotechs and global pharmaceutical enterprises, Modus Create offers specialized AWS services for the life sciences sector. These include generative AI enablement, data modernization, cloud infrastructure optimization, and secure digital product development. As an AWS Advanced Tier Services Partner and active AWS Marketplace provider, Modus aligns technical execution with strategic priorities to help life sciences customers deliver better outcomes, faster. Learn more at: https://moduscreate.com/partners/aws/
About Modus Create:
Modus Create is a digital product engineering firm dedicated to helping clients build competitive advantage through digital innovation. We support organizations with new product development, legacy modernization and migration, and strategic consulting. Our global team of strategists, designers, and technologists has created powerful digital experiences for some of the world's biggest brands. Learn more at moduscreate.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
a day ago
- Business Upturn
Lithios Beverages Drives Excitement in NYC with Successful Sampling Events and Times Square Billboard
Photo Courtesy of Lithios Beverages NEW YORK, Aug. 08, 2025 (GLOBE NEWSWIRE) — Lithios Beverages, an innovator in functional drinks inspired by the energizing potential of lithium, just wrapped up a slate of in-store sampling events across Manhattan and Brooklyn, including at Fairway Gardens Kips Bay, Brooklyn Fair, and 2131 Broadway Street. Led by Alex and Tina Genzer, Lithios Beverages stands out with its unique fusion of flavor and function. Recent samplings saw enthusiastic crowds exploring Lithios Beverages' trio of standout flavors: Berry, Electric Lime, and Orange Mango. 'The feedback has been incredible. Everyone connects with different flavors, and the positive energy at our events was contagious,' said Tina Genzer. The spontaneous excitement around the upcoming launch of Brain Fuel+ Hydration Drink Mix was undeniable, with guests eagerly reserving their spots after learning about its breakthrough formula. Crafted with a mineral-rich base and enhanced by Max Catalyst™ for faster absorption, it delivers 71+ trace minerals from ConcenTrace®, essential electrolytes, Vitamin C, and B12—all in a clean, highly bioavailable format. Science-backed functional ingredients like GeniusPure® Alpha GPC and SalidroPure® Salidrosides support immunity, focus, mental clarity, and natural energy, while helping the body adapt to stress and combat fatigue. Consumers are invited to sign up online ahead of the official launch to receive 10% off their first order. Dustin Elliott, chief brand officer at NNB Nutrition, shared: 'Lithios Beverages captures what NNB stands for—real progress in human performance. GeniusPure® is the most concentrated, clinically researched Alpha GPC, shown to improve cognitive function with just one serving. And SalidroPure™ delivers 99% pure, naturally fermented salidrosides, offering a sustainable alternative to Rhodiola without compromising potency.' The interactive environment saw customers trying creative flavor combinations and brainstorming cocktail ideas, showing buzz building up for Lithios Beverages' next product line. ' The energy was remarkable. People started blending flavors, exchanging recipes, and already envisioning new ways to enjoy our Brain Fuel+ Hydration Drink Mix,' noted co-founder Alexander Genzer. 'Clearly, New Yorkers are looking for hydration that truly supports mind and body.' Lively testimonials continue to flood the company's Instagram (@drinklithiosbeverages). Lithios Beverages also recently made its Times Square debut with stunning billboard spots. This overwhelming support has prompted Fairway Markets to request more sampling events and secure additional inventory. Industry recognition is following suit. Lithios Beverages was spotlighted in GI's recent 'Companies to Watch' report, drawing attention to the broader growth of functional drinks inspired by the dynamic properties associated with lithium. The report, which highlights the functional beverage sector through 2033, can be accessed in the Press and Media area of the Lithios Beverages website. 'We're honored by the excitement and curiosity Lithios Beverages is generating,' said Tina Genzer. 'Just as lithium powers modern technology, Lithios Beverages energizes everyday wellness. Our upcoming Brain Fuel+ Hydration will go even further to meet today's needs for clarity, resilience, and refreshment.' Lithios Beverages is continuing in-store sampling across NYC throughout July, with more events planned for September. It has also opened a round for early-stage investors. For more information, visit or follow @drinklithiosbeverages on Instagram. Contact information:Tina GenzerLithios Beverages Website: [email protected]
Business Insider
a day ago
- Business Insider
Is Amazon Stock (AMZN) a Buy? TipRanks AI Analyst Says Yes
Amazon (AMZN) attracts strong interest from investors and Wall Street analysts. Notably, TipRanks' A.I. Analyst also gave Amazon a positive rating, signaling confidence in the stock's potential. The tool assigns an Outperform rating to AMZN stock with a solid score of 81. Meanwhile, the A.I. analyst assigns a price target of $257 to AMZN stock, implying an upside of over 15% from the current levels. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. For context, TipRanks' A.I. Stock Analysis provides automated, data-backed evaluations of stocks across key metrics, offering users a clear and concise view of a stock's potential. Amazon's AI-driven score reflects its solid financial performance and encouraging details from its recent earnings call. For context, Amazon's Q2 net sales grew 13% year-over-year to $167.7 billion, surpassing Wall Street's estimate of $162.2 billion. Meanwhile, Amazon Web Services (AWS) remains the main profit engine, with sales rising 17.5% to $30.9 billion. Despite this, investors reacted negatively to the results, as AWS's performance failed to meet high expectations. For Q3, Amazon expects net sales between $174 billion and $179.5 billion, showing growth of 10% to 13%, higher than the analyst estimate of $173.27 billion. On the other hand, some technical indicators and valuation measures signal the need for caution. Below is the screenshot for reference. Wall Street Also Stays Bullish on AMZN Stock Following its Q2 results, several top-rated analysts have reiterated their Buy ratings and raised price targets on AMZN stock. Overall, analysts believe the recent dip in the stock presents an attractive buying opportunity for investors. Additionally, analysts applauded Amazon's recent announcement that OpenAI's open-weight models are now accessible through its AWS cloud platform. These models may not be the most advanced, but they provide great value by offering strong performance at a lower cost, making them appealing to many customers. What Is the Price Target for AMZN Stock? According to TipRanks, AMZN stock has a Strong Buy consensus rating based on 43 Buys and one Hold assigned in the last three months. At $264.21, the Amazon average share price target implies an upside of 18.6% from the current level.
Yahoo
a day ago
- Yahoo
Amazon (AMZN) Gets $272 Target as OpenAI Models Launch on AWS
Inc. (NASDAQ:AMZN) is one of the . On August 6, BofA Securities analyst Justin Post reiterated a Buy rating on the stock with a $272.00 price target. The rating affirmation follows OpenAI's announcement of new open weight models, the first models available on AWS (via Amazon Bedrock and Amazon SageMaker AI). The firm discussed how customers will be able to use Amazon Sagemaker and Amazon Guardrails. The analysts noted that even though the new OpenAI models don't represent OpenAI's 'leading edge' capabilities, they correspond well with Amazon's cost savings strategy. 'Customers will be able to use Amazon Sagemaker for pre-training, evaluation, and deployment, as well as Amazon Guardrails for security features. OpenAI's open weight models may not represent the 'leading edge' models (capabilities more similar to a lightweight version of the flagship GPT-4 model), but do fit well with Amazon's cost savings strategy, as gpt-oss-120b is suggested to be 3x more price-performant vs. Gemini, 5x more than DeepSeek-R1, and 2x vs. OpenAI's own o4 model.' Here is what AWS and OpenAI executives said about the strategic integration: AWS Director of Product Atul Deo stated: 'the unmatched size of our customer base marks a transformative shift in access to OpenAI's advanced technology', and OpenAI product lead Dmitry Pimenov stated, 'Together with AWS, we're providing powerful, flexible tools that make it easier than ever for customers to build, innovate, and scale.' Inc. (NASDAQ:AMZN) is an American technology company offering e-commerce, cloud computing, and other services, including digital streaming and artificial intelligence solutions. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
